News

Filter

Current filters:

None

8726 to 8735 of 97852 results

EU Parliament rejects ACTA by massive 478 vote from MEPs

05-07-2012

The controversial Anti-Counterfeiting Trade Agreement (ACTA) was rejected by the European Parliament…

EuropePatentsPharmaceuticalPoliticsRegulation

Germany's IQWiG finds no proof of added benefit for AstraZeneca's Caprelsa in thyroid cancer

05-07-2012

The German Institute for Quality and Efficiency in Health Care (IQWiG) has now examined the added benefit…

AstraZenecaCaprelsaEuropeOncologyPharmaceuticalPricingRegulation

Johnson & Johnson pulls EU submission for Velcade use in NHL

05-07-2012

The European Medicines Agency has been formally notified by US health care giant Johnson & Johnson's…

EuropeJanssen-CilagJohnson & JohnsonOncologyPharmaceuticalRegulationVelcade

Ferring Pharma gains rights for elobixibat from Albireo

05-07-2012

Swiss drugmaker Ferring Pharmaceuticals has entered into a licensing agreement with Albireo AB, a Sweden-based…

AlbireoBiotechnologyelobixibatFerring PharmaceuticalsGastro-intestinalsLicensingPharmaceutical

News briefs from Merck KGaA and Sanofi

05-07-2012

German drug major Merck KGaA )MRK: DE) revealed this morning that its Phase III EXPAND trial, which assessed…

cilengitideErbituxManagementMerck KGaAMergers & AcquisitionsPharmaceuticalResearchSanofi

Russia urged to open up its pharmaceuticals market to Indian imports

04-07-2012

Russia should open its booming $19 billion pharmaceuticals market and expedite the list of 500 drugs…

Asia-PacificEuropeGenericsMarkets & MarketingPoliticsRegulation

4% growth forecast for generic drugs market in Central Europe between 2012 and 2014

04-07-2012

According to Polish market research firm PMR's report, titled generic and innovative drugs market in…

EuropeGenericsMarkets & MarketingPatentsPharmaceutical

Slow-down of European bipolar therapy market set for short-term slowdown

04-07-2012

Patent expiry of key blockbuster atypical antipsychotic drugs is likely to cause a decline in growth…

AstraZenecaEuropeGenericsMarkets & MarketingNeurologicalPatentsPharmaceuticalPricingSeroquel

Global neuroendocrine carcinoma market to reach $475 million by 2019; report

04-07-2012

The global Neuroendocrine carcinoma therapeutics market was worth $127 million in 2011 and now the market…

AvastinBioSynthemaIpsenLutatheraMarkets & MarketingOncologyPharmaceuticalRocheSomatuline

8726 to 8735 of 97852 results

COMPANY SPOTLIGHT

Menarini

Back to top